Literature DB >> 24999277

Intracerebral hemorrhage after pipeline embolization: Management of antiplatelet agents and the case for point-of-care testing--case reports and review of literature.

Nohra Chalouhi1, Mario Zanaty2, Pascal M Jabbour2, Robert M Starke3, Stavropoula I Tjoumakaris2, Robert H Rosenwasser2, L Fernando Gonzalez2.   

Abstract

Entities:  

Keywords:  Flow diversion; Intracerebral hemorrhage; Pipeline embolization device; Platelet

Mesh：

Substances：

Year:  2014        PMID： 24999277     DOI： 10.1016/j.clineuro.2014.06.021

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  9 in total

1.  Middle cerebral artery pressure changes following Pipeline flow diversion.

Authors:  Denise Brunozzi; Sophia F Shakur; Fady T Charbel; Ali Alaraj
Journal:  Interv Neuroradiol       Date:  2018-02-13       Impact factor: 1.610

2.  Intracranial contrast transit times on digital subtraction angiography decrease more in patients with delayed intraparenchymal hemorrhage after Pipeline.

Authors:  Denise Brunozzi; Sophia F Shakur; Fady T Charbel; Ali Alaraj
Journal:  Interv Neuroradiol       Date:  2017-12-12       Impact factor: 1.610

3.  Risk Factors for Hemorrhagic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the International Retrospective Study of the Pipeline Embolization Device.

Authors:  W Brinjikji; G Lanzino; H J Cloft; A H Siddiqui; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 4.  Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature.

Authors:  Mary In-Ping Huang Cobb; Ali R Zomorodi; Erik F Hauck; Tony P Smith; L Fernando Gonzalez
Journal:  Childs Nerv Syst       Date:  2016-12-12       Impact factor: 1.475

5.  Clinical and angiographic outcomes in patients with intracranial aneurysms treated with the pipeline embolization device: intra-procedural technical difficulties, major morbidity, and neurological mortality decrease significantly with increased operator experience in device deployment and patient management.

Authors:  Josser E Delgado Almandoz; Yasha Kayan; Andrea Tenreiro; Adam N Wallace; Jill M Scholz; Jennifer L Fease; Anna M Milner; Maximilian Mulder; Kyle M Uittenbogaard; Oscar Tenreiro-Picón
Journal:  Neuroradiology       Date:  2017-10-06       Impact factor: 2.804

6.  Endovascular treatment of vertebral and basilar artery aneurysms with low-profile visualized intraluminal support device.

Authors:  Quanlong Hong; Wenqiang Li; Jing Ma; Peng Jiang; Yisen Zhang
Journal:  BMC Neurol       Date:  2021-05-15       Impact factor: 2.474

7.  The Combination of Stent and Antiplatelet Therapy May Be Responsible of Parenchymal Magnetic Susceptibility Artifacts after Endovascular Procedure.

Authors:  Fanny Bourhis-Guizien; Brieg Dissaux; Grégoire Boulouis; Douraied Ben Salem; Jean-Christophe Gentric; Julien Ognard
Journal:  Tomography       Date:  2021-11-13

8.  Utility of quantitative magnetic resonance angiography and non-invasive optimal vessel analysis for identification of complications and long-term hemodynamic changes in post-pipeline embolization patients.

Authors:  Brendan Ryu; Timothy G White; Kevin A Shah; Justin Turpin; Thomas Link; Amir R Dehdashti; Jeffrey M Katz; Karen Black; Henry H Woo
Journal:  Interv Neuroradiol       Date:  2021-08-04       Impact factor: 1.764

9.  Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms.

Authors:  Wonsoo Son; Dong-Hun Kang
Journal:  Front Neurol       Date:  2020-10-30       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.